Download Citation
Article Source:
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway
Atefi M,
von Euw E,
Attar N,
Ng C,
Chu C,
et al.
(2011)
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway.
PLOS ONE 6(12): e28973.
https://doi.org/10.1371/journal.pone.0028973